EFG Asset Management (North America) Corp. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
EFG Asset Management (North America) Corp. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,262,319
+3.0%
137,739
-2.7%
1.25%
+14.1%
Q2 2023$5,106,827
+15.9%
141,581
+22.6%
1.10%
+12.5%
Q1 2023$4,408,067
-37.9%
115,470
-7.3%
0.97%
-38.9%
Q4 2022$7,098,112
+19.1%
124,572
-17.4%
1.59%
+15.7%
Q3 2022$5,961,000
-21.2%
150,755
-12.3%
1.38%
-13.5%
Q2 2022$7,568,000
-35.5%
171,969
-41.6%
1.59%
-9.4%
Q1 2022$11,737,000
-1.3%
294,413
-0.4%
1.76%
+13.4%
Q4 2021$11,890,000295,6561.55%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders